Citations 2
Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series (P3-1.009)
Flanagan, Eoin P., Vilaseca, Andreu, Bilodeau, Philippe-Antoine, Jiang, Mulan , Said, Yana , Chen, Haiwen , Chen, John J., Pittock, Sean J., Sotirchos, Elias, Levy, Michael, Flanagan, Eoin P. , Vilaseca, Andreu , Bilodeau, Philippe-Antoine, Filippatou, Angeliki , Pittock, Sean J. , Sotirchos, Elias S. , Levy, Michael , Kister, Ilya
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab to Prevent Relapses in Neuromyelitis Optica Spectrum Disorder (NMOSD) (P3-1.001)
Bilodeau, Philippe-Antoine, Devlin, Michael, Bhattacharyya, Shamik, Salky, Rebecca, Mendoza, Juan Sebastian, Friede, Tim, Bennett, Jeffrey, Cree, Bruce, Palace, Jacqueline, Levy, Michael, Fujihara, Kazuo, Kim, Ho Jin, Flanagan, Eoin , Matiello, Marcelo, Paul, Friedemann, Vishnevetsky, Anastasia , Bhattacharyya, Shamik , Friede, Tim , Cree, Bruce , Palace, Jacqueline , Levy, Michael , Fujihara, Kazuo , Kim, Ho Jin , Flanagan, Eoin P. , Matiello, Marcelo , Paul, Friedemann
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available